Atrys Health, S.A. (ATRY.MC)

EUR 3.11

(0.32%)

Operating Income Summary of Atrys Health, S.A.

Atrys Health, S.A.'s latest annual operating income in 2023 was -1.58 Million EUR , down -54.66% from previous year.
Atrys Health, S.A.'s latest quarterly operating income in 2024 Q2 was 11.29 Million EUR , up 708.92% from previous quarter.
Atrys Health, S.A. reported an annual operating income of 8.36 Million EUR in 2022, up 167.81% from previous year.
Atrys Health, S.A. reported an annual operating income of -12.34 Million EUR in 2021, down -1355.41% from previous year.
Atrys Health, S.A. reported a quarterly operating income of 11.29 Million EUR for 2024 Q2, up 708.92% from previous quarter.
Atrys Health, S.A. reported a quarterly operating income of -123.5 Thousand EUR for 2023 Q1, up 98.57% from previous quarter.

Annual Operating Income Chart of Atrys Health, S.A. (2023 - 2012)

Historical Annual Operating Income of Atrys Health, S.A. (2023 - 2012)

Year	Operating Income	Operating Income Growth
2023	-1.58 Million EUR	-54.66%
2022	8.36 Million EUR	167.81%
2021	-12.34 Million EUR	-1355.41%
2020	983.02 Thousand EUR	-19.06%
2019	1.21 Million EUR	57.74%
2018	769.95 Thousand EUR	82.77%
2017	421.26 Thousand EUR	-11.32%
2016	475.03 Thousand EUR	122.41%
2015	213.58 Thousand EUR	-52.85%
2014	452.97 Thousand EUR	473.83%
2013	-121.17 Thousand EUR	-252.25%
2012	79.58 Thousand EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	1.39 Million EUR	302.31%
2024 Q2	11.29 Million EUR	708.92%
2023 Q1	-123.5 Thousand EUR	98.57%
2023 Q4	347 Thousand EUR	151.99%
2023 FY	3.79 Million EUR	-54.66%
2023 Q3	-667.5 Thousand EUR	-219.84%
2023 Q2	557 Thousand EUR	551.01%
2022 Q2	880 Thousand EUR	734.12%
2022 FY	8.36 Million EUR	167.81%
2022 Q3	4.37 Million EUR	396.59%
2022 Q1	105.5 Thousand EUR	100.32%
2022 Q4	-8.6 Million EUR	-296.96%
2021 Q4	-32.92 Million EUR	-1569.69%
2021 Q2	334.84 Thousand EUR	852.45%
2021 Q3	-1.97 Million EUR	-688.94%
2021 FY	-12.34 Million EUR	-1355.41%
2021 Q1	-44.5 Thousand EUR	-102.55%
2020 FY	983.02 Thousand EUR	-19.06%
2020 Q2	-138.65 Thousand EUR	0.0%
2020 Q1	-138.65 Thousand EUR	-129.86%
2020 Q3	1.74 Million EUR	1358.98%
2020 Q4	1.74 Million EUR	0.0%
2019 Q4	464.4 Thousand EUR	-51.74%
2019 Q2	466 Thousand EUR	98.34%
2019 Q3	962.24 Thousand EUR	106.49%
2019 Q1	234.94 Thousand EUR	-65.39%
2019 FY	1.21 Million EUR	57.74%
2018 Q1	219.65 Thousand EUR	49.46%
2018 FY	769.95 Thousand EUR	82.77%
2018 Q4	678.9 Thousand EUR	243.8%
2018 Q3	197.46 Thousand EUR	-55.16%
2018 Q2	440.36 Thousand EUR	100.48%
2017 Q4	146.96 Thousand EUR	0.0%
2017 FY	421.26 Thousand EUR	-11.32%
2017 Q2	69.47 Thousand EUR	0.0%
2017 Q1	69.47 Thousand EUR	136.21%
2017 Q3	146.96 Thousand EUR	111.54%
2016 Q1	-55.75 Thousand EUR	0.0%
2016 Q2	-55.75 Thousand EUR	0.0%
2016 FY	475.03 Thousand EUR	122.41%
2016 Q4	-191.88 Thousand EUR	0.0%
2016 Q3	-191.88 Thousand EUR	-244.15%
2015 FY	213.58 Thousand EUR	-52.85%
2014 FY	452.97 Thousand EUR	473.83%
2013 FY	-121.17 Thousand EUR	-252.25%
2012 FY	79.58 Thousand EUR	0.0%

Peer Operating Income Comparison of Atrys Health, S.A.

Name	Operating Income	Operating Income Difference
Biotechnologies Assets SA	2.65 Million EUR	159.607%
Pharma Mar, S.A.	-3.82 Million EUR	58.662%
Laboratorios Farmaceuticos Rovi, S.A.	220.25 Million EUR	100.718%